Skip to main content
LCTX $0.77 -5.87%
LCTX logo
LCTX · Lineage Cell Therapeutics, Inc.
Track LCTX — free
$0.77 -0.05 (-5.87%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$195.26M
Shares
252.95M
Volume · Nov 20 2.04M Avg daily vol (3M) 1.63M
All webcasts

Earnings call · FY2024 Q2

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2024 Earnings Call

Concluded Aug 8, 2024
Aug 8, 2024
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
Revenue $1.41M -56.3% YoY
Diluted EPS -$0.03
Gross margin · derived Q4 96.9% +0.8 pp YoY
Net income -$5.76M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document